Associate Director - CFIB Deal Enablement & Operations
Eli Lilly and Company
Summary
Lilly is one of the most active dealmakers in biopharma, and Corporate Finance & Investment Banking sits at the center of that activity. This role offers a rare combination: direct exposure to live transactions and a mandate to redesign how a large-cap pharma deal team works using artificial intelligence (AI). The Associate Director – Deal Enablement & AI Transformation will accelerate and drive transformation across Corporate Finance & Investment Banking (CFIB), the team that partners with Lilly's business development organization on the financial evaluation and execution of transactions, building the deal-agnostic engine that scales the team as Lilly expands its business development capacity.
Job description
Overview
Lilly is one of the most active dealmakers in biopharma, and Corporate Finance & Investment Banking sits at the center of that activity. This role offers a rare combination: direct exposure to live transactions and a mandate to redesign how a large-cap pharma deal team works using artificial intelligence (AI). The Associate Director – Deal Enablement & AI Transformation will accelerate and drive transformation across Corporate Finance & Investment Banking (CFIB), the team that partners with Lilly's business development organization on the financial evaluation and execution of transactions, building the deal-agnostic engine that scales the team as Lilly expands its business development capacity.
This Indianapolis based role defines the processes, standards, tools, and ways of working that power the end-to-end dealmaking process; leads strategy, innovation, and transformation projects; drives the continuous-improvement cadence that sharpens each successive deal; and delivers cross-cutting analyses that turn insights into decisive action for senior leadership. As a high-performing individual contributor, the role operates with significant independence and an owner mindset, stays close to live transactions and provides hands-on execution support, and brings best-in-class practices into CFIB. The role requires project management discipline, financial valuation acumen, hands-on AI and data fluency, and strong business partnering skills to influence stakeholders across CFIB, other finance functions, and the broader business development ecosystem.
Responsibilities
- Build and Scale the Operating Model: Define, implement, and continuously refine the processes, standards, templates, playbooks, and ways of working that power CFIB, including taking ownership of workstreams end to end.
- Partner Across CFIB, Finance, Corporate Business Development, and External Advisors: Build relationships with CFIB dealmakers, finance partners (Finance Transformation, Treasury, Accounting, R&D Finance, Tax, etc.), the broader business development ecosystem (Corporate Business Development, Legal, Alliance Management, etc.), and external advisors to surface opportunities, align on priorities, and provide ad hoc deal execution support.
- Accelerate and Drive Transformation and Innovation: Lead an evolving portfolio of strategy, innovation, and transformation projects across CFIB from scoping through implementation, including initiatives with executive visibility. Track emerging technology trends and best-in-class practices, engaging internal and external thought partners, and incorporate them into CFIB through automation and AI-enabled deal workflows.
- Build and Deploy AI-Enabled Deal Tools: Design, prototype, and deploy AI and automation solutions that measurably accelerate the deal process (e.g., AI-assisted diligence review, comparable-transaction screening, model and materials quality control, and first drafts of deal memos and leadership materials) using enterprise tools such as Claude, Microsoft Copilot, Cortex, and Power Platform, in partnership with Tech@Lilly; drive adoption across CFIB and track the value delivered.
- Drive Operational Excellence and Continuous Improvement: Facilitate learning forums such as post-deal insights sessions; translate insights into updated playbooks and decisive action; and simplify how CFIB supports deals.
- Deliver Cross-Cutting Analyses and Reporting: Produce deal-agnostic analyses that inform senior leadership, including enterprise strategic planning, Board-level materials, and other priorities as they emerge. Design deal reporting, KPIs, and scorecards that give leadership a clear, consistent view of CFIB activity and outcomes.
- Support Live Deals and Deal Operations: Provide hands-on execution support on live transactions (valuation, structuring analysis, and materials) as capacity requires, and serve as backup for key deal operations, processes, and controls.
Basic Qualifications
Bachelor's degree with 6+ years of experience in investment banking, corporate or business development, private equity or venture capital, transaction advisory, or a comparable deal-execution role OR an advanced degree (e.g., MBA, JD, or master's in finance) with 4+ years of experience in investment banking, corporate or business development, private equity or venture capital, transaction advisory, or a comparable deal-execution role.
Preferences
- Investment banking experience, ideally in healthcare or life sciences coverage or M&A
- Demonstrated track record of building and deploying AI or automation tools that are in active use (e.g., LLM-based workflows, agentic tools, prompt engineering, Python, or Power Platform), with the judgment to know where AI does and does not belong in a deal process
- Advanced degree (e.g., MBA)
- Experience in life sciences or biopharma business development or corporate development
- Strong financial modeling and valuation skills (e.g., DCF, risk-adjusted NPV) and working knowledge of deal structures (e.g., upfront payments, milestones, royalties, equity)
- Familiarity with enterprise financial data and systems, and with deal or pipeline management tools (e.g., CRM and deal-tracking platforms)
- Proven ability to work independently in a new or ambiguous environment
- Clear written and verbal communication, with experience preparing and presenting materials for senior leadership, including Board and executive committee materials
- Cross-functional project leadership with experience in transformation and change management
- Strong learning agility and commitment to continuous improvement and knowledge sharing
Requirements
- Bachelor's degree with 6+ years of experience in investment banking, corporate or business development, private equity or venture capital, transaction advisory, or a comparable deal-execution role OR an advanced degree (e.g., MBA, JD, or master's in finance) with 4+ years of experience in investment banking, corporate or business development, private equity or venture capital, transaction advisory, or a comparable deal-execution role
- Investment banking experience, ideally in healthcare or life sciences coverage or M&A
- Demonstrated track record of building and deploying AI or automation tools that are in active use (e.g., LLM-based workflows, agentic tools, prompt engineering, Python, or Power Platform)
- Advanced degree (e.g., MBA)
- Experience in life sciences or biopharma business development or corporate development
- Strong financial modeling and valuation skills (e.g., DCF, risk-adjusted NPV) and working knowledge of deal structures
- Familiarity with enterprise financial data and systems, and with deal or pipeline management tools
- Proven ability to work independently in a new or ambiguous environment
- Clear written and verbal communication, with experience preparing and presenting materials for senior leadership
- Cross-functional project leadership with experience in transformation and change management
- Strong learning agility and commitment to continuous improvement and knowledge sharing
Benefits
- 401(k) Matching
- Pension
- Vacation Benefits
- Medical, Dental & Vision
- Prescription Drug Benefits
- Flexible Spending Accounts
- Life Insurance
- Death Benefits
- Employee Assistance Program
- Fitness Benefits
- Employee Clubs & Activities
- Company Bonus
Company overview
Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.